Development of the PG x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing-Reference-Cited by-同舟云学术

Development of the PG x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Published:2019-06-12 Issue:4 Volume:106 Page:866-873
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wouden Cathelijne H.¹²^ORCID,van Rhenen Mandy H.³,Jama Wafa O.M.³,Ingelman‐Sundberg Magnus⁴^ORCID,Lauschke Volker M.⁴^ORCID,Konta Lidija⁵,Schwab Matthias⁶⁷^ORCID,Swen Jesse J.¹²^ORCID,Guchelaar Henk‐Jan¹²^ORCID

Affiliation:

1. Department of Clinical Pharmacy and ToxicologyLeiden University Medical Center Leiden The Netherlands

2. Leiden Network for Personalised Therapeutics Leiden The Netherlands

3. Royal Dutch Pharmacists Association (KNMP) The Hague The Netherlands

4. Section of PharmacogeneticsDepartment of Physiology and PharmacologyBiomedicum 5B Karolinska Institutet Stockholm Sweden

5. bio.logis Center for Human Genetics Frankfurt am Main Germany

6. Dr. Margarete Fischer‐Bosch Institute of Clinical Pharmacology Stuttgart Germany

7. Department of Clinical Pharmacology and Departments of Biochemistry and Pharmacy,University Tuebingen Tuebingen Germany

Funder

Horizon 2020 Framework Programme

Robert Bosch Stiftung

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1489

Reference50 articles.

1. Pharmacogenomics in the clinic

2. Pharmacogenomics: bench to bedside

3. Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions

4. A Randomized Trial of Genotype-Guided Dosing of Warfarin

5. Pharmacogenomic testing and response to warfarin

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategy and technologies of distribution and implementation of pharmacogenomics in clinical practice: foreign experience;Pharmacogenetics and Pharmacogenomics;2024-06-18

2. Drug-gene interactions in older patients with coronary artery disease;2024-05-16

3. Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-04-30

4. Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation;Pharmacogenomics;2024-04-12

5. Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options;European Journal of Human Genetics;2024-04-11